Susceptibility to aflatoxin B1-induced carcinogenesis correlates with tissue-specific differences in DNA repair activity in mouse and in rat

Cancer Research

Volumn 65, Issue 4, 2005, Pages 1265-1270

  Bedard, Leanne L ^a   Alessi, Manlio ^a   Davey, Scott ^a   Massey, Thomas E ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; DNA; GUANINE DERIVATIVE; NUCLEOTIDE; PLASMID DNA; PYRIDINE DERIVATIVE; 2,3 DIHYDRO 2 (N(7) GUANYL) 3 HYDROXYAFLATOXIN B1; 2,3-DIHYDRO-2-(N(7)-GUANYL)-3-HYDROXYAFLATOXIN B1; AFLATOXIN B1 FORMAMIDOPYRIMIDINE; AFLATOXIN B1-FORMAMIDOPYRIMIDINE; CARCINOGEN; DRUG DERIVATIVE; GUANINE; PYRIMIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; DNA ADDUCT; DNA REPAIR; DNA SYNTHESIS; FEMALE; IN VIVO STUDY; ISOTOPE LABELING; LIVER; LUNG; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; RAT; TISSUE DIFFERENTIATION; TISSUE REPAIR; ANIMAL; CHEMICALLY INDUCED DISORDER; COCARCINOGENESIS; DRUG EFFECT; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; LUNG TUMOR; METABOLISM; PHYSIOLOGY; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT;

AFLATOXIN B1; ANIMALS; CARCINOGENS; COCARCINOGENESIS; DNA; DNA REPAIR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GUANINE; LIVER; LIVER NEOPLASMS; LUNG; LUNG NEOPLASMS; MALE; MICE; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY;

EID: 13944269126     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3373     Document Type: Article

References (56)

1. Wogan GN. Aflatoxin carcinogenesis. Methods Cancer Res 1973;7:309-44.
2. Wogan GN. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res 1992;52: 2114-8s.
3. Hayes RB, Van Nieuwenhuize JP, Raatgever JW, ten Kate FJW. Aflatoxin exposures in the industrial setting: an epidemiological study of mortality. Food Chem Toxicol 1984;22:39-43.
4. 1 in two cases of lung cancer in man. J Cancer Res Clin Oncol 1981;100:221-4.
5. Dvorackova I, Polster M. Relation between aflatoxin producing aspergilloma and lung carcinoma. Microbiologie-Aliments-Nutrition 1984;2:187-92.
6. Dvorackova I. Aflatoxin inhalation and alveolar cell carcinoma. Br Med J 1986;1:691.
7. Guengerich FP. Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation and related reactions. Arch Biochem Biophys 2003;409:59-71.
8. 1 in human lung. Carcinogenesis 1996;17:2487-94.
9. 1 lung tumorigenesis. Exp Lung Res 2000;26:673-83.
10. 1 in vitro. Proc Natl Acad Sci U S A 1977;74:1870-4.
11. 1-DNA adduct formed in vivo in rat liver. Proc Natl Acad Sci U S A 1978;75:1745-9.
12. 1. Carcinogenesis 1982;3:723-5.
13. Wang J-S, Groopman J. DNA Damage by Mycotoxins. Mutat Res 1999;424:167-81.
14. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427-8.
15. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from Southern Africa. Nature 1991;350:429-31.
16. Newberne PM, Butler WH. Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: a review. Cancer Res 1969;29:236-44.
17. 1. Mol Carcinog 1999;26:62-7.
18. Eaton DL, Gallagher EP. Mechanisms of aflatoxin carcinogenesis. Annu Rev Pharmacol Toxicol 1994;34:135-72.
19. 1 in the rat and mouse. Toxicol Appl Pharmacol 1987;90:401-9.
20. 1-DNA adducts in human fibroblasts. Cancer Res 1981;41:5125-9.
21. Takahashi Y, Nakatsuru Y, Zhang S, et al. Enhanced spontaneous and aflatoxin-induced liver tumorigenesis in xeroderma pigmentosum group A gene-deficient mice. Carcinogenesis 2002;23:627-33.
22. 1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells. Cancer Res 1992;52:5668-73.
23. Costa RM, Chigancas V, da Silva GR, Carvalho H, Menck CF, The eukaryotic nucleotide excision repair pathway. Biochimie 2003;85:1083-99.
24. Wood RD, Biggerstaff M, Shivji MKK. Detection and measurement of nucleotide excision repair synthesis by mammalian cell extracts in vitro. Methods: A Companion to Methods in Enzymology 1995;7:163-75.
25. Salles B, Frit P, Provot C, Jaeg JP, Calsou P. In vitro eukaryotic DNA excision repair assays: an overview. Biochimie 1995;77:796-802.
26. Wood RD, Robins P, Lindahl T. Complementation of the xeroderma pigmentosum DNA repair defect in cell-free extracts. Cell 1988;53:97-106.
27. Aboussekhra A, Biggerstaff M, Shivji MK, et al. Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell 1995;80:859-68.
28. 7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases. Cancer Res 1986;46:3924-31.
29. 1: patterns of DNA adduct formation, removal, and excretion in relation to carcinogenesis. Drug Metab Rev 1982;13:581-602.
30. 1-S-glutathione in the rat. Xenobiotica 1987;17:139-53.
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
32. 1: the ultimate carcinogenic species. J Am Chem Soc 1988;110:7929-31.
33. 1: mechanistic studies. J Am Chem Soc 1994;116:1603-9.
34. 2 with rat liver DNA and histones in vivo. Carcinogenesis 1981;2:1371-3.
35. 1 DNA adducts by the UvrABC endonuclease of Escherichia coli. J Biol Chem 1993;268:7990-8002.
36. Coudore F, Calsou P, Salles B. DNA repair activity in protein extracts from rat tissues. FEBS Lett 1997;414:581-4.
37. Calsou P, Salles B. Measurement of damage-specific DNA incision by nucleotide excision repair in vitro. Biochem Biophys Res Commun 1994;202:788-95.
38. 1: a new metabolite. Chem Res Toxicol 1992;5:333-5.
39. 1. Proc Natl Acad Sci U S A 1985;82:3096-100.
40. 1-2,3-oxide. Mutat Res 1987;179:89-101.
41. Johnston DS, Stone MP. Replication of a site-specific traits-8,9-dihydro-8-(N7-guanyl)-9-hydroxyaflatoxin B(1) adduct by the exonuclease deficient Klenow fragment of DNA polymerase I. Chem Res Toxicol 2000;13:1158-64.
42. 1. Cancer Res 1981;41:197-203.
43. Smith ML, Chen IT, Zhan Q, O'Connor PM, Fornace AJ. Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 1995;10:1053-9.
44. Protic M, Roilides E, Levine AS, Dixon K. Enhancement of DNA repair capacity of mammalian cells by carcinogen treatment. Somat Cell Mol Genet 1988;14:351-7.
45. Germanier M, Defais M, Bohr VA, Larminat F. Transcription-coupled repair is inducible in hamster cells. Nucleic Acids Res 2000;28:4674-8.
46. 1 inhibition of rat liver nuclear RNA polymerase II activity in vivo. Carcinogenesis 1986;7:253-7.
47. 1 inhibition of nuclear RNA polymerase II activity. Carcinogenesis 1982;3:1005-9.
48. Smela ME, Hamm ML, Henderson PT, Harris CM, Harris TM, Essigmann JM. The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. Proc Natl Acad Sci U S A 2002;99:6655-60.
49. 1H NMR. Biochemistry 1998;37:4374-87.
50. 1 formamidopyrimidine adducts are preferentially repaired by the nucleotide excision repair pathway in vivo. Carcinogenesis 2004;25:1045-51.
51. 1-imidazole ring opened guanine adducts from DNA by formamidopyrimidine-DNA glycosylase. Carcinogenesis 1983;4:997-1000.
52. Margison GP, Pegg AE. Enzymatic release of 7-methylguanine from methylated DNA by rodent liver extracts. Proc Natl Acad Sci U S A 1981;78:861-5.
53. Balajee AS, Bohr VA. Genomic heterogeneity of nucleotide excision repair. Gene 2000;250:15-30.
54. Hanawalt PC, Ford JM, Lloyd DR. Functional characterization of global genomic DNA repair and its implications for cancer. Mutat Res 2003;544:107-14.
55. Tsurimoto T. PCNA, a multifunctional ring on DNA. Biochim Biophys Acta 1998;1443:23-39.
56. Riedl T, Hanaoka F, Egly JM. The comings and goings of nucleotide excision repair factors on damaged DNA. EMBO J 2003;22:5293-303.